Pharmaceuticals

Strong CAGR to Propel in the Montelukast Sodium Market and Beyond upto $5.89 Billion by 2029

August 22, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Projected CAGR for the Montelukast Sodium Market Size from 2025 to 2034?#_x000D_

There has been a significant upswing in the size of the montelukast sodium market in past years. Its growth is projected to surge from $3.86 billion in 2024 to $4.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.9%. This notable advancement in the previous period can be credited to factors such as escalating respiratory diseases, an aging populace, heightened levels of air contamination, burgeoning awareness and education, and broadening scope in emergent markets._x000D_

_x000D_

The market size of montelukast sodium is anticipated to experience robust expansion in the coming years. The market is projected to reach a value of $5.89 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.8%. The growth during the forecast period is expected to be driven by factors such as approval and launch, clinical studies, patent expiry, regulatory modifications, and physicians’ prescribing habits. The forecast period will be marked by significant trends including enhanced generic competition, a move towards combination therapies, growth in emerging markets, increased emphasis on pediatric use, and the implementation of digital health solutions._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp_x000D_

_x000D_

#Which Primay Drivers Are Accelerating Growth in the Montelukast Sodium Market?#_x000D_

The escalating incidence of asthma is predicted to drive the expansion of the montelukast sodium market in the future. Asthma is characterized as a persistent respiratory disorder with inflammation and restriction of the air passages, leading to recurring episodes of wheezing, breathlessness, tightening of the chest, and coughing. Environmental pollution, exposure to allergens, genetic factors, urbanization, lifestyle changes, and respiratory infections all contribute to the increased prevalence of asthma. As a leukotriene receptor antagonist, montelukast sodium aids in the prevention and management of asthma symptoms by inhibiting the effects of leukotrienes, which are involved in airway inflammation and restriction. For instance, the American Lung Association – a voluntary health organization from the United States – stated in July 2024 that approximately 44.2 million Americans or 13.5% of the population were diagnosed with asthma by a healthcare professional in 2022. As a result, the escalating incidence of asthma is fueling the expansion of the montelukast sodium market._x000D_

_x000D_

#Which Primary Segments of the Montelukast Sodium Market Are Driving Growth and Industry Transformations?#_x000D_

The montelukast sodium market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Crystal-like, Form-less Or Amorphous_x000D_

2) By Dosage Form: Tablets, Oral Solutions_x000D_

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium _x000D_

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=16123&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Montelukast Sodium Market?# Market?#_x000D_

North America was the largest region in the montelukast sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Technological Trends Are Reshaping the Montelukast Sodium Industry Dynamics?#_x000D_

Leading corporations in the montelukast sodium market are innovating new treatments, including easy-to-access generic over-the-counter (OTC) medications for individuals dealing with asthma and allergic rhinitis. OTC generic drugs, which don’t require a prescription, can typically be purchased at pharmacies or retail shops. For example, in July 2022, Fexofenadine HCL 180 mg and Pseudoephedrine HCL 240 mg were launched in the US by Dr. Reddy’s Laboratories, a pharmaceutical firm based in India. This medication, which offers temporary relief from nasal and sinus congestion resulting from colds or allergies, matches the formulation of Allegra-D 24 HR. By combining an antihistamine and a nasal decongestant, it helps to soothe symptoms like sneezing, a runny nose, itchy eyes, and throat irritation. It comes in 5, 10, and 15-count packs and presents a cost-effective, high-quality solution for those experiencing discomfort from upper respiratory issues._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Montelukast Sodium Market?#_x000D_

Montelukast sodium is a leukotriene receptor antagonist, meaning it works by blocking the action of leukotrienes that cause asthma symptoms and allergic reactions. It is used to manage and prevent symptoms of asthma and to relieve seasonal and perennial allergic rhinitis. Montelukast is typically administered orally in tablet form._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16123_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_